The Conversation (0)
Jun. 19, 2015 09:30AM PST
M Pharmaceutical Inc. (CSE:MQ,OTCMKTS:MPHMF) announced that is has added Dr. Michel Fattouche, a professor in the Department of Electrical and Computer Engineering at the University of Calgary, to the company’s Advisory Board.
M Pharmaceutical Inc. (CSE:MQ,OTCMKTS:MPHMF) announced that is has added Dr. Michel Fattouche, a professor in the Department of Electrical and Computer Engineering at the University of Calgary, to the company’s Advisory Board.
As quoted in the press release:
Dr. Fattouche, a registered Professional Engineer in the Province of Alberta, Canada, is a former “Calgarian of the Year” (2000) and “Prairies Entrepreneur of the Year” (2000) in Communications and Technology by Ernst and Young.
The research work attributed to Dr. Fattouche has led to 21 patents being issued and 14 filed, including his pioneering work and patents in W-OFDM (Wide-band Orthogonal Frequency Division Multiplexing). That work led to his co-founding of the trail-blazing Wi-LAN Inc. in 1993. Wi-LAN’s patented W-OFDM technology is being incorporated into the “WiMAX” Standard 802.16 developed by the Institute of Electrical and Electronics Engineers (IEEE).
Based on his related patents on Super-Resolution, Dr. Fattouche also co-founded Cell-Loc Inc. in 1995. Eight years later in 2003, Cell-Loc Inc. became Cell-Loc Location Technologies Inc., the developer of a family of network-based wireless location products that enable location-sensitive services.
The work of Dr. Fattouche has been widely cited internationally and he is viewed as a transformative leader in his field. He was named “Professor of the Year” by the Student Union for Teaching Excellence in the Department of Electrical and Computer Engineering at the University of Calgary in 1999.
Dr. Martin Mintchev, president and CEO of M Pharmaceutical, commented:
Given the vision of the Company as a leader in biomedical products reliant on innovative technologies, it only adds to our strength by having somebody of Dr. Michel Fattouche’s stature as one of our chief advisors. We’re very pleased to have Dr. Fattouche on our Advisory Board. His expertise and scope of knowledge in the field of electrical engineering and wireless communications will help us greatly as we move toward the final development and launch of technologies such as the e-Mosquito, gastro-intestinal neurostimulators and temporary controllable pseudobezoars.
Click here to read the M Pharmaceutical Inc. (CSE:MQ,OTCMKTS:MPHMF) press release
Click here to see the M Pharmaceutical Inc. (CSE:MQ,OTCMKTS:MPHMF) profile.